Payment overview · 2025
General Payments
$440.01
26 reported records · 9 companies
Healthcare provider profile · identity verified
Gregory M Flippo, MD
Allopathic & Osteopathic Physicians|Internal Medicine · TRUSSVILLE, AL · NPI 1033187109
Verified facts
What the public records show
CMS Open Payments records show Gregory M Flippo, MD received $440.01 in general payments during 2025 across 26 reported records.
Lundbeck LLC accounted for 35.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 9 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 196 claims for Rexulti by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 196 claims for Rexulti by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1752 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lundbeck LLC | Unresolved — no canonical attribution shown | $153.80 | 35.0% | 11 | 2025 |
| TOLMAR, INC. | Unresolved — no canonical attribution shown | $68.58 | 15.6% | 4 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $51.26 | 11.7% | 3 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $43.01 | 9.8% | 2 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $40.03 | 9.1% | 2 | 2025 |
| JAZZ PHARMACEUTICALS INC. | Unresolved — no canonical attribution shown | $27.16 | 6.2% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $22.83 | 5.2% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $18.63 | 4.2% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $14.71 | 3.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $440.01 | 26 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $172.43 | 12 | 2025 |
Source payment records
|
|||||
| JATENZO Normalized: jatenzo |
Drug | TOLMAR, INC. | $68.58 | 4 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $51.26 | 3 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $43.01 | 2 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $40.03 | 2 | 2025 |
Source payment records
|
|||||
| EPIDIOLEX Normalized: epidiolex |
Drug | JAZZ PHARMACEUTICALS INC. | $27.16 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $22.83 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $14.71 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $14.71 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 196 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
196 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
196 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1752 | 105 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
18 | 16 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2922 | 191 |
| Amlodipine Besylate | Amlodipine Besylate | 2182 | 123 |
| Levothyroxine Sodium | Levothyroxine Sodium | 2041 | 114 |
| Potassium Chloride | Potassium Chloride | 2035 | 114 |
| Trazodone Hcl | Trazodone Hcl | 2002 | 116 |
| Famotidine | Famotidine | 1985 | 108 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1844 | 157 |
| Eliquis | Apixaban | 1752 | 105 |
| Furosemide | Furosemide | 1507 | 101 |
| Metoprolol Succinate | Metoprolol Succinate | 1461 | 102 |
| Carvedilol | Carvedilol | 1456 | 64 |
| Escitalopram Oxalate | Escitalopram Oxalate | 1372 | 74 |
| Donepezil Hcl | Donepezil Hcl | 1301 | 70 |
| Mirtazapine | Mirtazapine | 1300 | 81 |
| Lisinopril | Lisinopril | 1251 | 74 |
| Buspirone Hcl | Buspirone Hcl | 1169 | 61 |
| Sertraline Hcl | Sertraline Hcl | 1040 | 56 |
| Quetiapine Fumarate | Quetiapine Fumarate | 972 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 944 | 76 |
| Metformin Hcl | Metformin Hcl | 929 | 52 |
| Citalopram Hbr | Citalopram Hydrobromide | 882 | 37 |
| Memantine Hcl | Memantine Hcl | 824 | 44 |
| Clopidogrel | Clopidogrel Bisulfate | 822 | 44 |
| Losartan Potassium | Losartan Potassium | 822 | 57 |
| Divalproex Sodium | Divalproex Sodium | 798 | 46 |
| Omeprazole | Omeprazole | 798 | 54 |
| Duloxetine Hcl | Duloxetine Hcl | 772 | 39 |
| Hydralazine Hcl | Hydralazine Hcl | 718 | 33 |
| Gabapentin | Gabapentin | 710 | 116 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 609 | 64 |
| Montelukast Sodium | Montelukast Sodium | 569 | 35 |
| Ropinirole Hcl | Ropinirole Hcl | 524 | 17 |
| Simvastatin | Simvastatin | 483 | 20 |
| Levetiracetam | Levetiracetam | 440 | 37 |
| Meloxicam | Meloxicam | 428 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 414 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 383 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 365 | 22 |
| Olanzapine | Olanzapine | 364 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 359 | 81 |
| Bumetanide | Bumetanide | 352 | 22 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 322 | 87 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 317 | 14 |
| Allopurinol | Allopurinol | 311 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 304 | 39 |
| Risperidone | Risperidone | 300 | 18 |
| Bupropion Xl | Bupropion Hcl | 299 | 21 |
| Paroxetine Hcl | Paroxetine Hcl | 298 | 19 |
| Lamotrigine | Lamotrigine | 285 | 12 |
| Alendronate Sodium | Alendronate Sodium | 281 | 12 |
| Tramadol Hcl | Tramadol Hcl | 281 | 63 |
| Aripiprazole | Aripiprazole | 267 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 265 | 73 |
| Xarelto | Rivaroxaban | 264 | 11 |
| Prednisone | Prednisone | 262 | 55 |
| Amiodarone Hcl | Amiodarone Hcl | 255 | 16 |
| Spironolactone | Spironolactone | 253 | 17 |
| Clonazepam | Clonazepam | 242 | 33 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 234 | 11 |
| Methocarbamol | Methocarbamol | 231 | 42 |
| Tradjenta | Linagliptin | 229 | suppressed |
| Ezetimibe | Ezetimibe | 228 | 27 |
| Metformin Hcl Er | Metformin Hcl | 226 | 37 |
| Alprazolam | Alprazolam | 215 | 38 |
| Baclofen | Baclofen | 207 | 20 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 203 | 45 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 199 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 198 | suppressed |
| Rexulti | Brexpiprazole | 196 | suppressed |
| Atenolol | Atenolol | 192 | 13 |
| Primidone | Primidone | 187 | 13 |
| Divalproex Sodium Er | Divalproex Sodium | 179 | 13 |
| Celecoxib | Celecoxib | 178 | 33 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 171 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 170 | 21 |
| Jardiance | Empagliflozin | 168 | 23 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 168 | 27 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 163 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 163 | suppressed |
| Valsartan | Valsartan | 161 | 11 |
| Januvia | Sitagliptin Phosphate | 156 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 154 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 150 | 20 |
| Lactulose | Lactulose | 148 | 32 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 146 | 15 |
| Sucralfate | Sucralfate | 146 | 23 |
| Ibuprofen | Ibuprofen | 145 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 144 | 45 |
| Doxepin Hcl | Doxepin Hcl | 141 | suppressed |
| Novolog | Insulin Aspart | 135 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 131 | 53 |
| Midodrine Hcl | Midodrine Hcl | 131 | 12 |
| Xifaxan | Rifaximin | 131 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 128 | suppressed |
| Nifedipine Er | Nifedipine | 128 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 128 | suppressed |
| Haloperidol | Haloperidol | 127 | suppressed |
| Lorazepam | Lorazepam | 126 | 38 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 122 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 121 | suppressed |
| Entresto | Sacubitril/Valsartan | 119 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 117 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 115 | 13 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 115 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 114 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 114 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 113 | suppressed |
| Azithromycin | Azithromycin | 112 | 64 |
| Lovastatin | Lovastatin | 112 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 112 | 19 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 111 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 111 | 24 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 106 | 29 |
| Telmisartan | Telmisartan | 104 | 26 |
| Levemir | Insulin Detemir | 100 | 20 |
| Temazepam | Temazepam | 100 | 12 |
| Oxcarbazepine | Oxcarbazepine | 99 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 96 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 93 | 56 |
| Bupropion Hcl | Bupropion Hcl | 88 | suppressed |
| Digoxin | Digoxin | 87 | suppressed |
| Latanoprost | Latanoprost | 87 | 19 |
| Nebivolol Hcl | Nebivolol Hcl | 87 | 12 |
| Topiramate | Topiramate | 87 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 87 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 85 | suppressed |
| Glipizide | Glipizide | 85 | suppressed |
| Loperamide | Loperamide Hcl | 85 | 49 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 83 | suppressed |
| Myrbetriq | Mirabegron | 82 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 82 | 17 |
| Drizalma Sprinkle | Duloxetine Hcl | 80 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 78 | 28 |
| Diltiazem Hcl | Diltiazem Hcl | 77 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 77 | 40 |
| Trulicity | Dulaglutide | 74 | suppressed |
| Lacosamide | Lacosamide | 73 | 12 |
| Fluconazole | Fluconazole | 72 | 41 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 72 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 71 | suppressed |
| Ondansetron Odt | Ondansetron | 70 | 29 |
| Pregabalin | Pregabalin | 70 | 18 |
| Austedo | Deutetrabenazine | 69 | suppressed |
| Methylprednisolone | Methylprednisolone | 67 | 40 |
| Tizanidine Hcl | Tizanidine Hcl | 67 | 11 |
| Verapamil Er | Verapamil Hcl | 67 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 66 | 18 |
| Meclizine Hcl | Meclizine Hcl | 66 | suppressed |
| Lansoprazole | Lansoprazole | 65 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 65 | suppressed |
| Fentanyl | Fentanyl | 63 | suppressed |
| Ozempic | Semaglutide | 62 | 12 |
| Ziprasidone Hcl | Ziprasidone Hcl | 62 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 61 | suppressed |
| Nystop | Nystatin | 60 | 31 |
| Linzess | Linaclotide | 58 | 13 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 57 | suppressed |
| Levofloxacin | Levofloxacin | 57 | 52 |
| Acetazolamide | Acetazolamide | 56 | suppressed |
| Amantadine | Amantadine Hcl | 56 | suppressed |
| Diazepam | Diazepam | 56 | suppressed |
| Cephalexin | Cephalexin | 55 | 34 |
| Amitriptyline Hcl | Amitriptyline Hcl | 54 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 54 | suppressed |
| Carbamazepine | Carbamazepine | 53 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 53 | suppressed |
| Entacapone | Entacapone | 52 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 52 | suppressed |
| Trandolapril | Trandolapril | 52 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 52 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 51 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 50 | suppressed |
| Tadalafil | Tadalafil | 49 | suppressed |
| Lidocaine | Lidocaine | 48 | 16 |
| Lubiprostone | Lubiprostone | 48 | suppressed |
| Alogliptin | Alogliptin Benzoate | 47 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 46 | suppressed |
| Mupirocin | Mupirocin | 45 | 30 |
| Testosterone Cypionate | Testosterone Cypionate | 44 | 15 |
| Vilazodone Hcl | Vilazodone Hcl | 44 | suppressed |
| Ramipril | Ramipril | 43 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 43 | 33 |
| Diclofenac Sodium | Diclofenac Sodium | 42 | 21 |
| Ingrezza | Valbenazine Tosylate | 41 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 41 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 40 | suppressed |
| Nystatin | Nystatin | 39 | 19 |
| Albuterol Sulfate | Albuterol Sulfate | 38 | 13 |
| Finasteride | Finasteride | 38 | suppressed |
| Olanzapine Odt | Olanzapine | 38 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 37 | 32 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 36 | suppressed |
| Scopolamine | Scopolamine | 36 | suppressed |
| Ramelteon | Ramelteon | 35 | suppressed |
| Insulin Aspart | Insulin Aspart | 34 | 17 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 34 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 33 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 32 | suppressed |
| Glimepiride | Glimepiride | 32 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 32 | suppressed |
| Irbesartan | Irbesartan | 32 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 31 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 30 | suppressed |
| Gemtesa | Vibegron | 29 | suppressed |
| Glipizide Er | Glipizide | 29 | suppressed |
| Amoxicillin | Amoxicillin | 28 | 16 |
| Balsalazide Disodium | Balsalazide Disodium | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Silodosin | Silodosin | 28 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 28 | suppressed |
| Trimethoprim | Trimethoprim | 28 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 27 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 27 | suppressed |
| Humalog | Insulin Lispro | 27 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 27 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 26 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 25 | 19 |
| Cefuroxime | Cefuroxime Axetil | 25 | 22 |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 12 |
| Brimonidine Tartrate | Brimonidine Tartrate | 24 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 24 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 24 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 24 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | suppressed |
| Pentasa | Mesalamine | 24 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 24 | suppressed |
| Briviact | Brivaracetam | 23 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 23 | suppressed |
| Levemir Flexpen | Insulin Detemir | 23 | suppressed |
| Budesonide | Budesonide | 22 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 22 | suppressed |
| Loxapine | Loxapine Succinate | 22 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 21 |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 21 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 20 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 20 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 20 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 20 | suppressed |
| Naproxen | Naproxen | 20 | suppressed |
| Cefdinir | Cefdinir | 19 | 18 |
| Cholestyramine | Cholestyramine (With Sugar) | 19 | 12 |
| Dapagliflozin | Dapagliflozin Propanediol | 19 | suppressed |
| Trospium Chloride | Trospium Chloride | 19 | suppressed |
| Admelog | Insulin Lispro | 18 | 11 |
| Belbuca | Buprenorphine Hcl | 18 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 18 | suppressed |
| Danazol | Danazol | 18 | suppressed |
| Methotrexate | Methotrexate Sodium | 18 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 18 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 18 | 16 |
| Santyl | Collagenase Clostridium Hist. | 18 | suppressed |
| Synthroid | Levothyroxine Sodium | 18 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Cilostazol | Cilostazol | 17 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 17 | suppressed |
| Ketoconazole | Ketoconazole | 17 | suppressed |
| Lumigan | Bimatoprost | 17 | suppressed |
| Mesalamine | Mesalamine | 17 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 17 | suppressed |
| Nexlizet | Bempedoic Acid/Ezetimibe | 17 | suppressed |
| Rivastigmine | Rivastigmine | 17 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 17 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 17 | suppressed |
| Erythromycin | Erythromycin Base | 16 | 12 |
| Gemfibrozil | Gemfibrozil | 16 | suppressed |
| Hydroxyurea | Hydroxyurea | 16 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 16 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Buprenorphine | Buprenorphine | 15 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 15 | suppressed |
| Dexamethasone | Dexamethasone | 15 | suppressed |
| Glucagon Emergency Kit | Glucagon | 15 | suppressed |
| Timolol Maleate | Timolol Maleate | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Lamotrigine Er | Lamotrigine | 14 | suppressed |
| Pentoxifylline | Pentoxifylline | 14 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 14 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 13 | suppressed |
| Clozapine | Clozapine | 13 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 13 | suppressed |
| Humulin R | Insulin Regular, Human | 13 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 13 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 13 | 12 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 12 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 12 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 12 | 12 |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Oxazepam | Oxazepam | 12 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 12 | suppressed |
| Valproic Acid | Valproic Acid | 12 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Pyridostigmine Bromide Er | Pyridostigmine Bromide | 11 | suppressed |
| Sotalol Af | Sotalol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $440.01 · 26 records | Lundbeck LLC | CAPLYTA, Cologuard Collection Kit, EPIDIOLEX, EVENITY, JATENZO, Kerendia, NURTEC ODT, REXULTI, ZAVZPRET | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lundbeck LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error